Divining progression in Parkinson disease with a blood test NfL

被引：2
|
作者：
Boylan, Laura S. [1 ,2 ,3 ,4 ]
Chio, Adriano [5 ]
机构：
[1] Bellevue Hosp, New York, NY 10016 USA
[2] NYU, Sch Med, New York, NY 10003 USA
[3] Albany Stratton VA Med Ctr, Albany, NY 12208 USA
[4] Essentia Hlth, Duluth, MN 55805 USA
[5] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy
来源：
NEUROLOGY | 2019年 / 93卷 / 11期
关键词：
D O I：
10.1212/WNL.0000000000008087
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [1] Blood NfL A biomarker for disease severity and progression in Parkinson disease
    Lin, Chin-Hsien
    Li, Cheng-Hsuan
    Yang, Kai-Chien
    Lin, Fang-Ju
    Wu, Chau-Chung
    Chieh, Jen-Jie
    Chiu, Ming-Jang
    NEUROLOGY, 2019, 93 (11) : E1104 - E1111
  • [2] Reader response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease
    van Rumund, Anouke
    Marques, Taina M.
    Esselink, Rianne A. J.
    Bloem, Bastiaan R.
    Verbeek, Marcel M.
    NEUROLOGY, 2020, 95 (14) : 657 - 658
  • [3] Author response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease
    Lin, Chin-Hsien
    Chiu, Ming-Jang
    NEUROLOGY, 2020, 95 (14) : 658 - 658
  • [4] Editors' note: Blood NfL: A biomarker for disease severity and progression in Parkinson disease
    Galetta, Steven
    NEUROLOGY, 2020, 95 (14) : 657 - 657
  • [5] Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
    Pilotto, Andrea
    Imarisio, Alberto
    Conforti, Francesca
    Scalvini, Andrea
    Masciocchi, Stefano
    Nocivelli, Sara
    Turrone, Rosanna
    Gipponi, Stefano
    Cottini, Elisabetta
    Borroni, Barbara
    Rizzetti, Maria Cristina
    Pizzi, Marina
    Bonanni, Laura
    Sturchio, Andrea
    Espay, Alberto J.
    Zetterberg, Henrik
    Ashton, Nicholas J.
    Hye, Abdul
    Padovani, Alessandro
    PARKINSONISM & RELATED DISORDERS, 2021, 87 : 41 - 47
  • [6] Relationship between plasma NFL and disease progression in Parkinson’s disease: a prospective cohort study
    Ruwei Ou
    Kuncheng Liu
    Junyu Lin
    Tianmi Yang
    Yi Xiao
    Qianqian Wei
    Yanbing Hou
    Chunyu Li
    Lingyu Zhang
    Zheng Jiang
    Bi Zhao
    Xueping Chen
    Wei Song
    Ying Wu
    Huifang Shang
    Journal of Neurology, 2024, 271 : 1837 - 1843
  • [7] Relationship between plasma NFL and disease progression in Parkinson's disease: a prospective cohort study
    Ou, Ruwei
    Liu, Kuncheng
    Lin, Junyu
    Yang, Tianmi
    Xiao, Yi
    Wei, Qianqian
    Hou, Yanbing
    Li, Chunyu
    Zhang, Lingyu
    Jiang, Zheng
    Zhao, Bi
    Chen, Xueping
    Song, Wei
    Wu, Ying
    Shang, Huifang
    JOURNAL OF NEUROLOGY, 2024, 271 (04) : 1668 - 1679
  • [8] Plasma Cystatin C Correlates with Plasma NfL Levels and Predicts Disease Progression in Parkinson's Disease
    Imarisio, Alberto
    Pilotto, Andrea
    Garrafa, Emirena
    Conforti, Francesca
    Masciocchi, Stefano
    Turrone, Rosanna
    Gipponi, Stefano
    Cottini, Elisabetta
    Rizzetti, Maria Cristina
    Porrini, Vanessa
    Gussago, Cristina
    Pizzi, Marina
    Guadagni, Fiorella
    Zetterberg, Henrik
    Ashton, Nicholas J.
    Hye, Abdul
    Padovani, Alessandro
    NEURODEGENERATIVE DISEASES, 2022, 21 (5-6) : 109 - 116
  • [9] Blood transcriptomic biomarker of disease progression in Parkinson's Disease
    Lee, R.
    Seok, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S736 - S736
  • [10] NfL as a biomarker for neurodegeneration and survival in Parkinson disease
    Backstrom, David
    Linder, Jan
    Mo, Susanna Jakobson
    Riklund, Katrine
    Zetterberg, Henrik
    Blennow, Kaj
    Forsgren, Lars
    Lenfeldt, Niklas
    NEUROLOGY, 2020, 95 (07) : E827 - E838
12345